Advisors Preferred »

Catalyst Pharmaceutical Partners shares owned by Advisors Preferred

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Advisors Preferred from 13F filings

Historical chart of Advisors Preferred investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Advisors Preferred consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Advisors Preferred

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.4M 381k 24.76
2024-12-31 $1.1M 50k 21.52

More positions owned by Advisors Preferred

State Street SPDR S&P 500 ETF Trust USD Class Etf (SPY)
iShares 1 3 Year Treasury Bond ETF USD Class Etf (SHY)
Invesco Nasdaq 100 ETF USD Class Etf (QQQM)
Schwab US Dividend Equity ETF USD Class Etf (SCHD)
iShares 0-3 Month Treasury Bond ETF USD Class Etf (SGOV)
State Street Energy Select Sector SPDR ETF USD Class Etf (XLE)
Vanguard Russell 1000 Growth ETF Etf (VONG)
iShares 7 10 Year Treasury Bond ETF USD Class Etf (IEF)
BondBloxx Bloomberg Six Month Target Duration US Treasury ETF Etf (XHLF)
Vanguard Dividend Appreciation ETF USD Class Etf (VIG)
NVIDIA Corporation (NVDA)
SPDR Bloomberg Convertible Securities ETF ETF Etf (CWB)
SPDR Bloomberg 1-3 Month T-Bill ETF USD Class Etf (BIL)
BNY Mellon US Large Cap Core Equity ETF USD Class Etf (BKLC)
WisdomTree US LargeCap Dividend Fund USD Class Etf (DLN)

View all positions for Advisors Preferred

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Deerfield Management Company
Dimensional Fund Advisors
Fundsmith
Bank of America Corporation
American Century Companies
Geode Capital Management
Morgan Stanley
Renaissance Technologies
Vanguard Portfolio Management
Royce & Associates
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners